Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic Models

Area of Science:

• Oncology
• Pharmacometrics
• Drug Development

Background:

• The evolution of cancer treatments, including immunotherapies and combination therapies, necessitates novel approaches in drug development.
• Tumor dynamics modeling is increasingly adopted by pharmaceutical companies and regulatory bodies.
• This modeling is also being explored for personalized cancer treatment strategies.

Purpose of the Study:

• To review and discuss the applications of tumor dynamics modeling in oncology drug development.
• To highlight the growing role of model-informed drug development (MIDD).
• To identify limitations and areas for future research in tumor dynamics modeling.

Main Methods:

• Review of current literature and applications of tumor dynamics modeling.
• Discussion of the integration of modeling into drug development and regulatory processes.
• Exploration of the use of these models in personalized medicine.

Main Results:

• Tumor dynamics modeling supports oncology drug development and approval in various capacities.
• Significant adoption of these modeling techniques by industry and regulatory agencies.
• Emerging applications in personalized cancer therapy approaches.

Conclusions:

• Tumor dynamics modeling is a valuable tool in modern oncology drug development.
• Continued research is needed to address current limitations and expand applications.
• Enhanced collaboration among clinical investigators, statisticians, and pharmacometricians is essential for progress.